An Open-Label, Multicenter, Phase 1b/2 Study to Evaluate Necitumumab in Combination with Gemcitabine and Cisplatin in the First-Line Treatment of Patients with Advanced (Stage IV) Squamous Non-Small Cell Lung Cancer (NSCLC)

被引：0
|
作者：
Tamura, Tomohide [1 ]
Nishio, Makoto [2 ]
Yamamoto, Nobuyuki [3 ]
Ohe, Yuichiro [1 ]
Wolff, Katharina [4 ]
Tsujimoto, Mika [5 ]
Enatsu, Sotaro [4 ]
Nakagawa, Kazuhiko [6 ]
机构：
[1] Natl Canc Ctr, Thorac Oncol, Tokyo, Japan
[2] Canc Inst Hosp Jfcr, Thorac Med Oncol, Tokyo, Japan
[3] Wakayama Med Univ Hosp, Med Oncol, Wakayama, Japan
[4] Eli Lilly Japan, Med Sci, Kobe, Hyogo, Japan
[5] Eli Lilly Japan, Stat Sci, Kobe, Hyogo, Japan
[6] Kinki Univ, Fac Med, Med Oncol, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
gemcitabine-cisplatin; necitumumab; squamous non-small cell lung cancer; trial in progress;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.01-080
引用
收藏
页码：S664 / S665
页数：2
相关论文
共 50 条
  • [31] Open-label, single arm, multicenter, phase 11 study on the efficacy and safety of cetuximab in combination with cisplatin and gemcitabine as 1st-line therapy in patients with advanced non-small cell lung cancer
    Barata, Fernando
    Parente, Barbara
    Teixeira, Encarnacao
    Costa, Agostinho
    Fernandes, Ana
    Pimentel, Francisco L.
    Andrade, Sofia
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S290 - S291
  • [32] A Phase 1b, Open-Label Study to Evaluate the Safety of Ganitumab (AMG 479) in Combination With Gemcitabine as First-line Therapy in Patients With Metastatic Pancreatic Cancer
    Ikeda, M.
    Okusaka, T.
    Fukutomi, A.
    Otani, S.
    Shibayama, K.
    Takubo, T.
    Gansert, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S467 - S467
  • [33] A phase II first-line study of gemcitabine, carboplatin, and bevacizumab (GCB) in advanced (adv) stage non-squamous non-small cell lung cancer (NSCLC)
    Krupitskaya, Y.
    Ganjoo, K.
    Lavori, P. W.
    Kumar, A.
    Clement-Duchene, C.
    Zhao, G.
    Padda, S.
    San Pedro-Salcedo, M.
    Wakelee, H. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [34] First-line avelumab in combination with cetuximab and chemotherapy in patients with advanced squamous non-small cell lung cancer (NSCLC)
    Andric, Z. G.
    Galffy, G.
    Cobo Dols, M.
    Szima, B.
    Stojanovic, G.
    Petrovic, M. D.
    Felip Font, E.
    Vicente Baz, D.
    Ponce Aix, S.
    Juan-Vidal, O.
    Tehenes, S.
    Szalai, Z.
    Losonczy, G.
    Calles Blanco, A.
    Bernabe, R.
    Duecker, K.
    Zhou, D.
    Schroeder, A.
    Guezel, G.
    Ciardiello, F.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S753 - S754
  • [35] Phase II study of bevacizumab in combination with cisplatin and docetaxel as first-line treatment of patients (p) with metastatic non-squamous non-small cell lung cancer (NSCLC)
    Ferrer, N.
    Cobo, M.
    Paredes, A.
    Mendez, M.
    Munoz-Langa, J.
    Rueda, A.
    de Mon, M. Alvarez
    Sanchez-Hernandez, A.
    Gallego, R.
    Torrego, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [36] A phase II trial of adding cetuximab to cisplatin and gemcitabine as first-line therapy in advanced non-small cell lung cancer (NSCLC)
    Barata, F.
    Parente, B.
    Teixeira, E.
    Costa, A.
    Fernandes, A.
    Pimentel, F. L.
    Carvalho, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [37] BO17704: a phase III study of first-line cisplatin and gemcitabine with bevacizumab or placebo in patients with advanced or recurrent non-squamous non-small cell lung cancer (NSCLC)
    Reck, Martin
    von Pawel, Joachim
    Zatloukal, Petr
    Ramlau, Rodryg
    Gorbounova, Vera
    Hirsh, Vera
    Leighl, Natasha
    Mezger, Joerg
    Archer, Venice
    Manegold, Christian
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S360 - S361
  • [38] Paclitaxel, cisplatin and gemcitabine combination chemotherapy in stage IV non-small cell lung cancer (NSCLC):: A phase II study.
    Cortes, J
    Rodriguez, J
    Calvo, E
    Martinez-Monge, R
    Fernández-Hildago, O
    Garzón, C
    Santisteban, M
    de Irala, J
    Azinovic, I
    Brugarolas, A
    ANNALS OF ONCOLOGY, 2000, 11 : 118 - 118
  • [39] A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
    Sanjay Goel
    Umang Swami
    Kirushna Kumar
    Christian Dittrich
    Larisa Reyderman
    Minish Jain
    Joseph Aisner
    James Song
    Daniel P. Petrylak
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 567 - 578
  • [40] A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer
    Goel, Sanjay
    Swami, Umang
    Kumar, Kirushna
    Dittrich, Christian
    Reyderman, Larisa
    Jain, Minish
    Aisner, Joseph
    Song, James
    Petrylak, Daniel P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (03) : 567 - 578
12345